We are live on
!
Find out more
RP
Rowlandmiller & Partners Portfolio holdings
AUM
$549M
1-Year Est. Return
36.2%
This Fund
S&P 500
This Quarter
Est. Return
+8.44%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$383M
AUM Growth
+$31.7M
(+9%)
Cap. Flow
+$6.16M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
35.16%
Holding
176
New
16
Increased
57
Reduced
46
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$4.07M |
| 2 |
T. Rowe Price
TROW
|
+$1.59M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22M |
| 4 |
Verizon
VZ
|
+$903K |
| 5 |
Gentex
GNTX
|
+$681K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$2.71M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$653K |
| 3 |
Vulcan Materials
VMC
|
+$647K |
| 4 |
Bio-Techne
TECH
|
+$451K |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$344K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24% |
| 2 | Financials | 14.36% |
| 3 | Healthcare | 13.68% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
US Bancorp
USB
$99.6B
| $117K | 0.03% |
+2,106
| New | +$105K |
|
152
Manulife Financial
MFC
$74B
| $109K | 0.03% |
+5,063
| New | +$101K |
|
153
Thermo Fisher Scientific
TMO
$212B
| $105K | 0.03% |
230
| – | – |
|
154
Granite Construction
GVA
$5.43B
| $104K | 0.03% |
+2,575
| New | +$89.1K |
|
155
Cisco
CSCO
$457B
| $103K | 0.03% |
+1,999
| New | +$93.8K |
|
156
MiMedx Group
MDXG
$622M
| $103K | 0.03% |
+10,000
| New | +$96.6K |
|
157
iShares US Healthcare Providers ETF
IHF
$1.26B
| $102K | 0.03% |
+2,030
| New | +$99.3K |
|
158
iShares US Medical Devices ETF
IHI
$3.37B
| $101K | 0.03% |
+1,830
| New | +$101K |
|
159
Eaton
ETN
$170B
| – | – |
-941
| Closed | -$113K |
|
|
160
iShares US Treasury Bond ETF
GOVT
$43.5B
| – | – |
-12,638
| Closed | -$344K |
|
|
MZTI
161
The Marzetti Company
MZTI
$3.04B
| – | – |
-885
| Closed | -$163K |
|
|
162
Vulcan Materials
VMC
$36.7B
| – | – |
-4,362
| Closed | -$647K |
|
163
Viatris
VTRS
$20.5B
| – | – |
-7,388
| Closed | -$138K |
|
|
MXIM
164
DELISTED
Maxim Integrated Products
MXIM
| – | – |
-7,370
| Closed | -$653K |
|
Similar funds
AMG
AI
LWP
WCP
BCM
HIS
AA
V
Rowlandmiller & Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Rowlandmiller & Partners held 176 positions worth $383M, up 9% from $351M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rowlandmiller & Partners's Q1 2021 filing shows 16 new, 57 increased, 46 reduced and 7 closed positions. Its largest new stake was Expeditors International: 6,939 shares worth $747K. The largest sale was Dentsply Sirona, an estimated $2.71M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Rowlandmiller & Partners's largest Q1 2021 buy was Expeditors International: 6,939 shares worth $747K.
- Rowlandmiller & Partners added most to AbbVie in Q1 2021, an estimated $4.07M increase.
- Rowlandmiller & Partners's biggest Q1 2021 reduction was Dentsply Sirona, cutting an estimated $2.71M.
- Rowlandmiller & Partners fully exited Maxim Integrated Products in Q1 2021, selling an estimated $653K.
- Rowlandmiller & Partners's ten largest holdings make up 35% of its $383M portfolio in Q1 2021.
- Rowlandmiller & Partners opened 16 new positions and closed 7 in Q1 2021.
- Rowlandmiller & Partners's portfolio value rose 9% quarter-over-quarter to $383M.
Based on Rowlandmiller & Partners's 13F filing for Q1 2021, filed 11 May 2021.